NasdaqGS:ADUS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. More Details


Snowflake Analysis

Excellent balance sheet with solid track record.


Similar Companies

Share Price & News

How has Addus HomeCare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ADUS is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: ADUS's weekly volatility (5%) has been stable over the past year.


Market Performance


7 Day Return

8.4%

ADUS

3.7%

US Healthcare

1.5%

US Market


1 Year Return

9.4%

ADUS

17.3%

US Healthcare

22.3%

US Market

Return vs Industry: ADUS underperformed the US Healthcare industry which returned 16.4% over the past year.

Return vs Market: ADUS underperformed the US Market which returned 22.1% over the past year.


Shareholder returns

ADUSIndustryMarket
7 Day8.4%3.7%1.5%
30 Day-4.2%3.3%8.8%
90 Day18.8%15.1%10.8%
1 Year9.4%9.4%18.9%17.3%25.1%22.3%
3 Year215.3%215.3%41.4%35.5%49.5%39.6%
5 Year324.8%324.8%84.9%71.6%105.8%83.3%

Long-Term Price Volatility Vs. Market

How volatile is Addus HomeCare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Addus HomeCare undervalued compared to its fair value and its price relative to the market?

45.8x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: ADUS ($104.37) is trading above our estimate of fair value ($80.35)

Significantly Below Fair Value: ADUS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: ADUS is poor value based on its PE Ratio (45.8x) compared to the US Healthcare industry average (23.4x).

PE vs Market: ADUS is poor value based on its PE Ratio (45.8x) compared to the US market (19.4x).


Price to Earnings Growth Ratio

PEG Ratio: ADUS is poor value based on its PEG Ratio (3x)


Price to Book Ratio

PB vs Industry: ADUS's PB Ratio (3.2x) is in line with the US Healthcare industry average.


Next Steps

Future Growth

How is Addus HomeCare forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

15.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ADUS's forecast earnings growth (15.1% per year) is above the savings rate (2.2%).

Earnings vs Market: ADUS's earnings (15.1% per year) are forecast to grow slower than the US market (21.9% per year).

High Growth Earnings: ADUS's earnings are forecast to grow, but not significantly.

Revenue vs Market: ADUS's revenue (8.9% per year) is forecast to grow slower than the US market (10.2% per year).

High Growth Revenue: ADUS's revenue (8.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ADUS's Return on Equity is forecast to be low in 3 years time (10.1%).


Next Steps

Past Performance

How has Addus HomeCare performed over the past 5 years?

24.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ADUS has high quality earnings.

Growing Profit Margin: ADUS's current net profit margins (4.7%) are higher than last year (3.1%).


Past Earnings Growth Analysis

Earnings Trend: ADUS's earnings have grown significantly by 24.1% per year over the past 5 years.

Accelerating Growth: ADUS's earnings growth over the past year (90.2%) exceeds its 5-year average (24.1% per year).

Earnings vs Industry: ADUS earnings growth over the past year (90.2%) exceeded the Healthcare industry 22.6%.


Return on Equity

High ROE: ADUS's Return on Equity (7%) is considered low.


Next Steps

Financial Health

How is Addus HomeCare's financial position?


Financial Position Analysis

Short Term Liabilities: ADUS's short term assets ($299.4M) exceed its short term liabilities ($93.7M).

Long Term Liabilities: ADUS's short term assets ($299.4M) exceed its long term liabilities ($94.1M).


Debt to Equity History and Analysis

Debt Level: ADUS's debt to equity ratio (12.1%) is considered satisfactory.

Reducing Debt: ADUS's debt to equity ratio has increased from 0% to 12.1% over the past 5 years.

Debt Coverage: ADUS's debt is well covered by operating cash flow (125.3%).

Interest Coverage: ADUS's interest payments on its debt are well covered by EBIT (23.5x coverage).


Balance Sheet


Next Steps

Dividend

What is Addus HomeCare current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ADUS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ADUS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ADUS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ADUS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ADUS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.9yrs

Average management tenure


CEO

R. Allison (64 yo)

4.92yrs

Tenure

US$1,992,513

Compensation

Mr. R. Dirk Allison has been the Chief Executive Officer and President of Addus HealthCare Inc. since January 16, 2016. Mr. Allison has been the Chief Executive Officer and President at Addus HomeCare Corp...


CEO Compensation Analysis

Compensation vs Market: R.'s total compensation ($USD1.99M) is below average for companies of similar size in the US market ($USD4.20M).

Compensation vs Earnings: R.'s compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
R. Allison
CEO, President & Director4.92yrsUS$1.99m0.33%
$ 5.3m
Brian Poff
CFO, Executive VP4.58yrsUS$930.80k0.14%
$ 2.2m
Sean Gaffney
Executive VP & Chief Legal Officer1.67yrsUS$1.87m0.056%
$ 892.7k
David Tucker
Executive VP & Chief Development Officer2.92yrsUS$1.48m0.044%
$ 701.1k
Michael Wattenbarger
Executive VP & Chief Information Officer1.42yrsUS$1.47m0.029%
$ 454.4k
W. Bickham
COO & Executive VP3.92yrsUS$1.67m0.18%
$ 2.9m
Monica Raines
Senior VP & Chief Compliance Officer2.58yrsno datano data
Laurie Manning
Executive VP & Chief Human Resource Officer3.33yrsUS$952.83k0.087%
$ 1.4m
Darby Anderson
Executive VP & Chief Strategy Officer13.17yrsUS$911.99k0.19%
$ 3.0m
Diane Kumarich
Senior Vice President of National Contracts & Business Development2.58yrsno datano data
Paul Akin
Senior Vice President of Project Management & Integration2.92yrsno datano data
Matthew Howland
Senior Vice President of Operations2.92yrsno datano data

2.9yrs

Average Tenure

55yo

Average Age

Experienced Management: ADUS's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
R. Allison
CEO, President & Director4.92yrsUS$1.99m0.33%
$ 5.3m
Mark First
Independent Director14.25yrsUS$138.77k0.14%
$ 2.2m
Steven Geringer
Independent Chairman4.92yrsUS$174.52k0.14%
$ 2.2m
Michael Earley
Independent Director6.75yrsUS$162.27k0.076%
$ 1.2m
Darin Gordon
Independent Director4.17yrsUS$149.77k0.042%
$ 668.2k
Susan Weaver
Independent Director4.17yrsUS$128.77k0.039%
$ 617.5k
Jean Rush
Independent Director2.17yrsUS$139.77k0.019%
$ 306.9k

4.9yrs

Average Tenure

63yo

Average Age

Experienced Board: ADUS's board of directors are considered experienced (4.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: ADUS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Addus HomeCare Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Addus HomeCare Corporation
  • Ticker: ADUS
  • Exchange: NasdaqGS
  • Founded: 1979
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$1.583b
  • Shares outstanding: 15.66m
  • Website: https://www.addus.com

Number of Employees


Location

  • Addus HomeCare Corporation
  • 6303 Cowboys Way
  • Suite 600
  • Frisco
  • Texas
  • 75034
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ADUSNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDOct 2009
A41DB (Deutsche Boerse AG)YesCommon StockDEEUROct 2009

Biography

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/12/04 23:04
End of Day Share Price2020/12/04 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.